Clinical Trial Update: What’s on the Horizon in Diabetes?

Clinical Trial Update: What’s on the Horizon in Diabetes? is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Nov 22, 2017 - Nov 22, 2020.

Intended Learners:
This activity is designed for primary care physicians, general practitioners, family medicine specialists, internists, pediatricians, nurse practitioners, nurses, physician assistants, pharmacists, registered dietitians, certified diabetes educators, and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic syndrome.

Accreditation:
CME:
NACCME designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

CNE:
This continuing nursing education activity awards 0.50 contact hour.
This continuing nursing activity awards up to 0.25 pharmacology credits.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credit™ through its reciprocity agreements.

CPE For Pharmacists:
This activity is approved for 0.50 contact hour (0.05 CEU) of continuing pharmacy education: 0276-0000-17-065-HO1-P

CPE For Dietitians:
North American Center for Continuing Medical Education, LLC (NACCME) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 0.5 Continuing Professional Education unit (CPEU) for completion of this activity/material.

Learning Objectives:
After completing this activity, participants should be able to:
• Explain the importance, the benefits, and the limitations of clinical trials and their results
• Summarize the recent clinical trial data involving diabetes mellitus with heart failure (HF)
• Assess the antidiabetic drugs that are most appropriate for patients with diabetes mellitus with HF

Additional details will be posted as soon as they are available.